Prevention of sodium lauryl sulfate irritant contact dermatitis by Pro-Q aerosol foam skin protectant.
Eczematous skin disease is a serious work-related illness. Since 1995, reimbursement by insurance companies for treatment of skin diseases has become the largest cost source in some countries. This study was a randomized controlled trial (N = 20) of the efficacy of Pro-Q, a skin protectant product, in the prevention of contact dermatitis from sodium lauryl sulfate and urushiol, the resinous sap of poison ivy and poison oak. Pro-Q was significantly effective in reducing the irritation from sodium lauryl sulfate but did not prevent the allergic reaction to urushiol.
D000279:Administration, Cutaneous; D000336:Aerosols; D002396:Catechols / Q000009:adverse effects; D017453:Dermatitis, Irritant / Q000517:prevention & control*; D009783:Dermatitis, Occupational / Q000209:etiology / Q000517:prevention & control; D011040:Dermatitis, Toxicodendron / Q000517:prevention & control; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003902:Detergents / Q000009:adverse effects*; D004129:Dimethylpolysiloxanes; D004311:Double-Blind Method; D004485:Eczema / Q000139:chemically induced / Q000517:prevention & control; D005990:Glycerol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007509:Irritants / Q000009:adverse effects*; D010947:Plants, Toxic; D020011:Protective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D012841:Simethicone / Q000008:administration & dosage / Q000627:therapeutic use*; D012967:Sodium Dodecyl Sulfate / Q000009:adverse effects*; D012251:Toxicodendron